Showing 1 - 8 results of 8 for search 'P.Jeffrey Conn', query time: 0.03s Refine Results
  1. 1
    Development of allosteric modulators of GPCRs for treatment of CNS disorders

    Development of allosteric modulators of GPCRs for treatment of CNS disorders by Hilary Highfield Nickols, P. Jeffrey Conn

    Published 2014-01-01
    Get full text
    Article
  2. 2
    MGluR5 mediates the interaction between late-LTP, network activity, and learning.

    MGluR5 mediates the interaction between late-LTP, network activity, and learning. by Arthur Bikbaev, Sergey Neyman, Richard Teke Ngomba, P Jeffrey Conn, Ferdinando Nicoletti, Denise Manahan-Vaughan

    Published 2008-05-01
    Get full text
    Article
  3. 3
    Correction: MGluR5 Mediates the Interaction between Late-LTP, Network Activity, and Learning.

    Correction: MGluR5 Mediates the Interaction between Late-LTP, Network Activity, and Learning. by Arthur Bikbaev, Sergey Neyman, Richard Teke Ngomba, P. Jeffrey Conn, Ferdinando Nicoletti, Denise Manahan-Vaughan

    Published 2008-01-01
    Get full text
    Article
  4. 4
    3293 Region Specific Dysregulation of Dopaminergic Signaling in Mice Displaying Excessive Over-Grooming

    3293 Region Specific Dysregulation of Dopaminergic Signaling in Mice Displaying Excessive Over-Grooming by Daniel Foster, Samantha Yohn, Muhammad Mahmood, Madigan Lavery, Daniel O’Brien, Weimin Peng, P. Jeffrey Conn

    Published 2019-03-01
    Get full text
    Article
  5. 5
    Evaluation of Synthetic Cytochrome P450-Mimetic Metalloporphyrins To Facilitate “Biomimetic” Biotransformation of a Series of mGlu5 Allosteric Ligands

    Evaluation of Synthetic Cytochrome P450-Mimetic Metalloporphyrins To Facilitate “Biomimetic” Biotransformation of a Series of mGlu5 Allosteric Ligands by Christopher C. Presley, Charles K. Perry, Elizabeth S. Childress, Matthew J. Mulder, Vincent B. Luscombe, Alice L. Rodriguez, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley

    Published 2019-07-01
    Get full text
    Article
  6. 6
    mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits

    mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits by James Maksymetz, Nellie E. Byun, Deborah J. Luessen, Brianna Li, Robert L. Barry, John C. Gore, Colleen M. Niswender, Craig W. Lindsley, Max E. Joffe, P. Jeffrey Conn

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Discovery of “Molecular Switches” within a Series of mGlu5 Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an M1 PAM Chemotype

    Discovery of “Molecular Switches” within a Series of mGlu5 Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an... by Lisa Barbaro, Alice L. Rodriguez, Ashlyn N. Blevins, Jonathan W. Dickerson, Natasha Billard, Olivier Boutaud, Jerri L. Rook, Colleen M. Niswender, P.Jeffrey Conn, Darren W. Engers, Craig W. Lindsley

    Published 2021-08-01
    Get full text
    Article
  8. 8
    A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes

    A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes by Nicole M. Fisher, Aqeela AlHashim, Aditi B. Buch, Hana Badivuku, Manar M. Samman, Kelly M. Weiss, Gabriela I. Cestero, Mark D. Does, Jerri M. Rook, Craig W. Lindsley, P. Jeffrey Conn, Rocco G. Gogliotti, Colleen M. Niswender

    Published 2021-02-01
    Get full text
    Article

Search Tools: